Biotechnology Apellis Announces Dr. Peter Hillmen, Renowned Hematologist and PNH Expert, to Join Company May 3, 2022
Biotechnology Editas Medicine to Present Pipeline and Platform Data Demonstrating Progress Towards Developing Transformative Gene Editing Medicines at the American Society of Gene and Cell Therapy Annual Meeting May 2, 2022
Biotechnology Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference May 2, 2022
Biotechnology Apellis Announces Detailed 18-Month Results from Phase 3 DERBY and OAKS Studies of Pegcetacoplan for Geographic Atrophy (GA) at ARVO Annual Meeting May 2, 2022
Biotechnology Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Should You Buy? May 2, 2022
Biotechnology Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? May 2, 2022